GB-236

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameGB-236

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors

TargetsProprotein convertase subtilisin kexin type 9

Therapy Area/IndicationsHyperlipidemias

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesGenor Biopharma Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenor Biopharma Co Ltd

Active IndicationsN/A

Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A